- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- monomer
- Ligands
- 1 x BGC- GLC- RY7: 4,6-dideoxy-4-{[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose-(1-4)-beta-D-glucopyranose
- 1 x GLC- RY7: 4,6-dideoxy-4-{[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
GLC-RY7.2: 10 residues within 4Å:- Chain A: W.74, W.75, Y.78, Q.79, A.120, V.170, G.171, D.306, H.311
- Ligands: BGC-GLC-RY7.1
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:Q.79, A:D.306, A:H.311, A:Q.79, A:V.170
- Hydrophobic interactions: A:A.120
- Water bridges: A:D.121, A:D.121, A:G.171
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 3 residues within 4Å:- Chain A: Q.279, S.412
- Ligands: EDO.14
Ligand excluded by PLIPEDO.5: 2 residues within 4Å:- Chain A: G.340, R.396
Ligand excluded by PLIPEDO.6: 5 residues within 4Å:- Chain A: N.391, A.394, S.454, K.455, A.492
Ligand excluded by PLIPEDO.7: 6 residues within 4Å:- Chain A: D.244, G.246, G.247, E.248, I.250, S.251
Ligand excluded by PLIPEDO.8: 3 residues within 4Å:- Chain A: A.294, D.296, R.297
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: S.26, G.27, R.28, G.54
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: R.275, N.307, Q.308, G.315, V.318, T.320
Ligand excluded by PLIPEDO.11: 2 residues within 4Å:- Chain A: N.371, S.377
Ligand excluded by PLIPEDO.12: 3 residues within 4Å:- Chain A: Y.321, P.324, W.386
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: W.407, W.408, D.409
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain A: Q.281, G.411
- Ligands: EDO.4
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain A: R.385, W.386, R.387, Q.388
- Ligands: EDO.22
Ligand excluded by PLIPEDO.16: 2 residues within 4Å:- Chain A: K.325, Q.326
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain A: F.264, D.268, N.307, A.313, G.314, G.315, V.318
Ligand excluded by PLIPEDO.18: 2 residues within 4Å:- Chain A: N.162, N.166
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain A: N.176, G.178, W.210, D.213
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain A: Q.405, N.406, G.420, S.421, G.441
Ligand excluded by PLIPEDO.21: 4 residues within 4Å:- Chain A: S.437, R.472, A.473, S.474
Ligand excluded by PLIPEDO.22: 4 residues within 4Å:- Chain A: P.324, K.328, W.386
- Ligands: EDO.15
Ligand excluded by PLIPEDO.23: 3 residues within 4Å:- Chain A: D.402, E.403, G.420
Ligand excluded by PLIP- 2 x SR: STRONTIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rhimi, M. et al., Structural and Functional Characterization of Drosophila melanogaster alpha-Amylase. Molecules (2023)
- Release Date
- 2023-08-16
- Peptides
- Alpha-amylase A: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- monomer
- Ligands
- 1 x BGC- GLC- RY7: 4,6-dideoxy-4-{[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose-(1-4)-beta-D-glucopyranose
- 1 x GLC- RY7: 4,6-dideoxy-4-{[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}-alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x SR: STRONTIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rhimi, M. et al., Structural and Functional Characterization of Drosophila melanogaster alpha-Amylase. Molecules (2023)
- Release Date
- 2023-08-16
- Peptides
- Alpha-amylase A: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
B